SEC Form 4 · accession 0001104659-18-038400
Axsome Therapeutics, Inc. · AXSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger Jeffs
Director
Period of report
Jun 1, 2018
Accepted (ET)
Jun 5, 2018 · 8:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001579428
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $3.45 | Jun 1, 2018 | A | 13,000 | A | Jun 1, 2019 | Jun 1, 2028 | Common Stock | 13,000 | 13,000 | D |
Explanation of responses
- F1The option vests in full on the one-year anniversary of the date of grant, June 1, 2019.